ii4sm - Scientific Advisory Board
The Scientific Advisory Board plays a critical role in ensuring that ii4sm is provided with the highest standard of advice to improve the way data is collected, stored and analyzed and that ii4sm is aware of global trends, best practices and standards in its fields of activity. The members of the ii4sm Scientific Advisory Board are renowned experts in their fields
Scientific Advisory Board
- Olivier Bodenreider, MD, PhD, (US National Library of Medicine)
- Thomas B. Cueni (Secretary General of Interpharma)
- Susan Ellenberg, PhD (Associate Dean for Clinical Research, University of Pennsylvania School of Medicine, Professor of Biostatistics and Epidemiology)
- Brigitte Franke-Bray, FFPM (Director of DIA Europe)
- Trevor G. Gibbs, MD (Chair and former GlaxoSmithKline SVP for Medical Governance and Pharmacovigilance)
- Judith Kramer, MD, MS (Associate Professor of Medicine in the Division of General Internal Medicine at the Duke University School of Medicine)
- Charles Mead, MD, MSc (Chief Technology Officer, Center for Bioinformatics and Information Technology, National Cancer Institute, Rockville)
- Panos Tsintis, PhD (Choice Pharma, former EMEA Head of Sector for Pharmacovigilance and Post-authorisation Safety and Efficacy of Medicines)
- Beat Widler, (Global Head of Pharma Development Quality, Roche)